BamSEC and AlphaSense Join Forces
Learn More

Assertio Holdings Inc. – Plans of Reorganization, Merger, Acquisition or Similar

Formerly NASDAQ: ASRT
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1
from 8-K 112 pages Agreement and Plan of Merger by and Among Zydus Worldwide Dmcc as Parent Zara Merger Sub Inc. as Purchaser, Assertio Holdings, Inc. as the Company, and Zydus Pharmaceuticals (USA) Inc., for the Limited Purposes Set Forth Herein Dated as of May 13, 2026
12/34/56
EX-2.1
from SC TO-C 111 pages Agreement and Plan of Merger by and Among Zydus Worldwide Dmcc as Parent Zara Merger Sub Inc. as Purchaser, Assertio Holdings, Inc. as the Company, and Zydus Pharmaceuticals (USA) Inc., for the Limited Purposes Set Forth Herein Dated as of May 13, 2026
12/34/56
EX-2.1
from 8-K 111 pages Agreement and Plan of Merger by and Among Zydus Worldwide Dmcc as Parent Zara Merger Sub Inc. as Purchaser, Assertio Holdings, Inc. as the Company, and Zydus Pharmaceuticals (USA) Inc., for the Limited Purposes Set Forth Herein Dated as of May 13, 2026
12/34/56
EX-2.1
from SC TO-C 161 pages Amended and Restated Agreement and Plan of Merger by and Among Garda Therapeutics, Inc. as Parent Audi Merger Sub, Inc. as Purchaser, and Assertio Holdings, Inc. as the Company Dated as of May 1, 2026
12/34/56
EX-2.1
from 8-K 161 pages Amended and Restated Agreement and Plan of Merger by and Among Garda Therapeutics, Inc. as Parent Audi Merger Sub, Inc. as Purchaser, and Assertio Holdings, Inc. as the Company Dated as of May 1, 2026
12/34/56
EX-2.1
from SC TO-C 190 pages Agreement and Plan of Merger by and Among Garda Therapeutics, Inc. as Parent Audi Merger Sub, Inc. as Purchaser, and Assertio Holdings, Inc. as the Company Dated as of April 8, 2026
12/34/56
EX-2.1
from SC TO-C 190 pages Agreement and Plan of Merger by and Among Garda Therapeutics, Inc. as Parent Audi Merger Sub, Inc. as Purchaser, and Assertio Holdings, Inc. as the Company Dated as of April 8, 2026
12/34/56
EX-2.1
from 8-K/A 190 pages Agreement and Plan of Merger by and Among Garda Therapeutics, Inc. as Parent Audi Merger Sub, Inc. as Purchaser, and Assertio Holdings, Inc. as the Company Dated as of April 8, 2026
12/34/56
EX-2.1
from 8-K 190 pages Agreement and Plan of Merger by and Among Garda Therapeutics, Inc. as Parent Audi Merger Sub, Inc. as Purchaser, and Assertio Holdings, Inc. as the Company Dated as of April 8, 2026
12/34/56
EX-2.1
from 425 143 pages Agreement and Plan of Merger Among Assertio Holdings, Inc. Spade Merger Sub 1, Inc. and Spectrum Pharmaceuticals, Inc. Dated as of April 24, 2023
12/34/56
EX-2.1
from 8-K 143 pages Agreement and Plan of Merger Among Assertio Holdings, Inc. Spade Merger Sub 1, Inc. and Spectrum Pharmaceuticals, Inc. Dated as of April 24, 2023
12/34/56
EX-2.1
from 10-K 55 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Both (I) Not Material and (II) Is of the Type That the Registrant Treats as Private or Confidential. Asset Purchase Agreement by and Between Otter Pharmaceuticals, LLC, Antares Pharma, Inc., and Assertio Holdings, Inc. Dated as of December 15, 2021
12/34/56
EX-2.1
from 8-K12B 7 pages Agreement and Plan of Merger
12/34/56